FFCP PHASE1:Mm9::chr7:52494658..52494665,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=12493|HGNC=|MCL_coexpression_id=18|UniProt=Q3U429|association_with_transcript=-173bp_to_ENSMUST00000033063_5end|description=CAGE_peak_13_at_Cd37_5end|id=chr7:52494658..52494665,-|ontology_enrichment_celltype=CL:0000553!1.67e-20!6;CL:0000556!1.67e-20!6;CL:0000050!1.84e-13!9;CL:0000414!6.81e-11!11;CL:0002027!1.12e-10!3;CL:0002006!1.12e-10!3;CL:0002024!1.12e-10!3;CL:0000839!4.09e-09!13;CL:0002031!1.43e-07!25;CL:0000763!2.81e-07!16|ontology_enrichment_celltype_v019_2=CL:0000553,2.49e-17,6;CL:0000556,2.49e-17,6;CL:0000945,1.55e-12,1;CL:0000236,1.55e-12,1;CL:0000826,1.55e-12,1;CL:0000050,8.55e-12,9;CL:0000839,2.31e-08,13;CL:0002031,1.53e-07,25;CL:0000763,6.65e-07,16|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002106!2.21e-09!6;UBERON:0004457!2.21e-09!6;UBERON:0000042!2.21e-09!6;UBERON:0004854!2.21e-09!6;UBERON:0009034!2.21e-09!6;UBERON:0002095!2.21e-09!6;UBERON:0004782!2.21e-09!6;UBERON:0003281!2.21e-09!6;UBERON:0009664!2.21e-09!6;UBERON:0002296!2.21e-09!6;UBERON:0005602!2.21e-09!6;UBERON:0001179!2.21e-09!6;UBERON:0006293!2.21e-09!6;UBERON:0003887!2.48e-08!10;UBERON:0002193!6.36e-08!48;UBERON:0002371!2.81e-07!16;UBERON:0002390!4.20e-07!45;UBERON:0003061!4.20e-07!45;UBERON:0001474!9.48e-07!22;UBERON:0004765!9.48e-07!22;UBERON:0001434!9.48e-07!22|ontology_enrichment_uberon_v019_2=UBERON:0000029,4.30e-12,1;UBERON:0001097,4.30e-12,1;UBERON:0003968,4.30e-12,1;UBERON:0001467,4.30e-12,1;UBERON:0002193,2.66e-08,48;UBERON:0002405,2.66e-08,48;UBERON:0002106,3.41e-08,6;UBERON:0004457,3.41e-08,6;UBERON:0000042,3.41e-08,6;UBERON:0004854,3.41e-08,6;UBERON:0009034,3.41e-08,6;UBERON:0002095,3.41e-08,6;UBERON:0004782,3.41e-08,6;UBERON:0003281,3.41e-08,6;UBERON:0009664,3.41e-08,6;UBERON:0002296,3.41e-08,6;UBERON:0005602,3.41e-08,6;UBERON:0001179,3.41e-08,6;UBERON:0006293,3.41e-08,6;UBERON:0002371,6.65e-07,16|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.666219523631325,0.607425802169478,0.699561878128147,3.47008381894061,1.7824876368746,2.12194825899015,0,0.0992909512008853,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.18786951509699,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0.11418387971906,1.55362730188303,0,0,0,0,0,0,0,0,0,0,0,0.220841518460394,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.373220911830279,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.199141273254367,0,0,0,0,0,0,0,0,0,0,0,0,0.196558995113203,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.221464689648775,0,1.14704320301017,0.345369963731791,0.289298117163023,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.316036757935816,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.512612642393558,0,0,0.753473828018764,1.36694227721025,1.83022538565218,0,0.139951452323658,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0974578807397524,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.191288332068843,0,0|short_description=p13@Cd37}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=12493 | |||
|HGNC= | |||
|MCL_coexpression_id=18 | |||
|TSSclassifier=NA | |||
|UniProt=Q3U429 | |||
|association_with_transcript=-173bp_to_ENSMUST00000033063_5end | |||
|cluster_id=chr7:52494658..52494665,- | |||
|description=CAGE_peak_13_at_Cd37_5end | |||
|id=chr7:52494658..52494665,- | |||
|ontology_enrichment_celltype=CL:0000553!1.67e-20!6;CL:0000556!1.67e-20!6;CL:0000050!1.84e-13!9;CL:0000414!6.81e-11!11;CL:0002027!1.12e-10!3;CL:0002006!1.12e-10!3;CL:0002024!1.12e-10!3;CL:0000839!4.09e-09!13;CL:0002031!1.43e-07!25;CL:0000763!2.81e-07!16 | |||
|ontology_enrichment_celltype_v019_2=CL:0000553,2.49e-17,6;CL:0000556,2.49e-17,6;CL:0000945,1.55e-12,1;CL:0000236,1.55e-12,1;CL:0000826,1.55e-12,1;CL:0000050,8.55e-12,9;CL:0000839,2.31e-08,13;CL:0002031,1.53e-07,25;CL:0000763,6.65e-07,16 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002106!2.21e-09!6;UBERON:0004457!2.21e-09!6;UBERON:0000042!2.21e-09!6;UBERON:0004854!2.21e-09!6;UBERON:0009034!2.21e-09!6;UBERON:0002095!2.21e-09!6;UBERON:0004782!2.21e-09!6;UBERON:0003281!2.21e-09!6;UBERON:0009664!2.21e-09!6;UBERON:0002296!2.21e-09!6;UBERON:0005602!2.21e-09!6;UBERON:0001179!2.21e-09!6;UBERON:0006293!2.21e-09!6;UBERON:0003887!2.48e-08!10;UBERON:0002193!6.36e-08!48;UBERON:0002371!2.81e-07!16;UBERON:0002390!4.20e-07!45;UBERON:0003061!4.20e-07!45;UBERON:0001474!9.48e-07!22;UBERON:0004765!9.48e-07!22;UBERON:0001434!9.48e-07!22 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000029,4.30e-12,1;UBERON:0001097,4.30e-12,1;UBERON:0003968,4.30e-12,1;UBERON:0001467,4.30e-12,1;UBERON:0002193,2.66e-08,48;UBERON:0002405,2.66e-08,48;UBERON:0002106,3.41e-08,6;UBERON:0004457,3.41e-08,6;UBERON:0000042,3.41e-08,6;UBERON:0004854,3.41e-08,6;UBERON:0009034,3.41e-08,6;UBERON:0002095,3.41e-08,6;UBERON:0004782,3.41e-08,6;UBERON:0003281,3.41e-08,6;UBERON:0009664,3.41e-08,6;UBERON:0002296,3.41e-08,6;UBERON:0005602,3.41e-08,6;UBERON:0001179,3.41e-08,6;UBERON:0006293,3.41e-08,6;UBERON:0002371,6.65e-07,16 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.666219523631325,0.607425802169478,0.699561878128147,3.47008381894061,1.7824876368746,2.12194825899015,0,0.0992909512008853,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.18786951509699,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0.11418387971906,1.55362730188303,0,0,0,0,0,0,0,0,0,0,0,0.220841518460394,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.373220911830279,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.199141273254367,0,0,0,0,0,0,0,0,0,0,0,0,0.196558995113203,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.221464689648775,0,1.14704320301017,0.345369963731791,0.289298117163023,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.316036757935816,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.512612642393558,0,0,0.753473828018764,1.36694227721025,1.83022538565218,0,0.139951452323658,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0974578807397524,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.191288332068843,0,0 | |||
|short_description=p13@Cd37 | |||
}} |
Latest revision as of 20:59, 26 September 2015
Short description: | p13@Cd37 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_13_at_Cd37_5end |
Coexpression cluster: | MCL_coexpression_mm9:18 |
Association with transcript: | -173bp_to_ENSMUST00000033063_5end |
EntrezGene: | Cd37 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
megakaryocyte progenitor cell | 2.49e-17 | 6 |
megakaryocyte | 2.49e-17 | 6 |
lymphocyte of B lineage | 1.55e-12 | 1 |
B cell | 1.55e-12 | 1 |
pro-B cell | 1.55e-12 | 1 |
megakaryocyte-erythroid progenitor cell | 8.55e-12 | 9 |
myeloid lineage restricted progenitor cell | 2.31e-08 | 13 |
hematopoietic lineage restricted progenitor cell | 1.53e-07 | 25 |
myeloid cell | 6.65e-07 | 16 |
Ontology term | p-value | n |
---|---|---|
lymph node | 4.30e-12 | 1 |
axillary lymph node | 4.30e-12 | 1 |
peripheral lymph node | 4.30e-12 | 1 |
shoulder | 4.30e-12 | 1 |
hemolymphoid system | 2.66e-08 | 48 |
immune system | 2.66e-08 | 48 |
spleen | 3.41e-08 | 6 |
cavity lining | 3.41e-08 | 6 |
serous membrane | 3.41e-08 | 6 |
gastrointestinal system mesentery | 3.41e-08 | 6 |
stomach region | 3.41e-08 | 6 |
mesentery | 3.41e-08 | 6 |
gastrointestinal system serosa | 3.41e-08 | 6 |
mesentery of stomach | 3.41e-08 | 6 |
gut mesentery | 3.41e-08 | 6 |
dorsal mesentery | 3.41e-08 | 6 |
dorsal mesogastrium | 3.41e-08 | 6 |
peritoneal cavity | 3.41e-08 | 6 |
spleen primordium | 3.41e-08 | 6 |
bone marrow | 6.65e-07 | 16 |